Physician

Robert T. Sperling, M.D.

According to 2025 Medicare claims, Robert Sperling, M.D. (NPI: 1558351387) practices interventional cardiology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is REGENTS UNIV OF CALIFORNIA UCSF (NPI: 1124439807; TIN: 943281662) and primary practice location at 94939-1142.

Sperling's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,109 traditional Medicare patients, billed 4,109 HCPCS/CPT codes, and received $261,343 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 5,992 prescription claims across 916 beneficiaries totaling $1,236,218 in drug costs, led by Eliquis (Apixaban). 2016 DME data shows 25 claims. Open Payments data shows 27 records totaling $959. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $416,328 to $1,236,218. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,363	4,101	$281,504
2016	1,316	3,735	$272,021
2017	1,341	3,664	$242,743
2018	1,147	3,119	$234,135
2019	1,159	2,832	$217,518
2020	961	2,482	$199,143
2021	1,101	3,286	$266,085
2022	1,018	2,791	$246,072
2023	1,030	2,890	$234,830
2024	1,109	4,109	$261,343

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	484	4,884	$416,328
2016	511	5,234	$478,142
2017	543	5,385	$559,041
2018	576	5,620	$664,307
2019	644	5,723	$811,430
2020	688	6,193	$1,020,327
2021	811	6,434	$1,221,241
2022	847	5,960	$1,207,543
2023	872	5,285	$1,150,885
2024	916	5,992	$1,236,218

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	25	$971
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	85	87	$184
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	734	1,169	$103
93798	Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services	103	220	$24
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	619	937	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	215	239	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	307	23,414	$456,314
Repatha Sureclick	Evolocumab	171	10,658	$206,442
Xarelto	Rivaroxaban	95	7,235	$133,167
Praluent Pen	Alirocumab	94	5,832	$102,340
Entresto	Sacubitril/Valsartan	57	3,015	$63,215

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$959	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert T. Sperling, M.D.?

Tedicare shows public-source Medicare data for Robert T. Sperling, M.D. (NPI 1558351387), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert T. Sperling, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert T. Sperling, M.D.?

Robert T. Sperling, M.D. is linked to REGENTS UNIV OF CALIFORNIA UCSF (billing NPI 1124439807) in the available physician profile data.

Does Robert T. Sperling, M.D. have Open Payments data?

Robert T. Sperling, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.